Yueming Zhu
- Department of Pharmacology & Chemical Biology
Assistant Professor
- (404) 727-9948
- yueming.zhu@emory.edu
- Lab website
Overview
Yueming's research interest centers on molecular mechanisms of breast tumor progression, metastasis, and breast cancer treatment, particular from the aspects of genome stability, tumor immunology and drug development.
Academic Appointment
- Assistant Professor, Pharmacology and Chemical Biology, Emory University School of Medicine
Research
Publications
-
Pharmacological Dissection Identifies Retatrutide Overcomes the Therapeutic Barrier of Obese TNBC Treatments through Suppressing the Interplay between Glycosylation and Ubiquitylation of YAP.
Adv Sci (Weinh) Volume: 12 Page(s): e2407494
03/01/2025 Authors: Cui X; Zhu Y; Zeng L; Zhang M; Uddin A; Gillespie TW; McCullough LE; Zhao S; Torres MA; Wan Y -
Tuning Immune-Cold Tumor by Suppressing USP10/B7-H4 Proteolytic Axis Reinvigorates Therapeutic Efficacy of ADCs.
Adv Sci (Weinh) Volume: 11 Page(s): e2400757
10/01/2024 Authors: Zeng L; Zhu Y; Cui X; Chi J; Uddin A; Zhou Z; Song X; Dai M; Cristofanilli M; Kalinsky K -
Pharmacological suppression of the OTUD4/CD73 proteolytic axis revives antitumor immunity against immune-suppressive breast cancers.
J Clin Invest Volume: 134
03/26/2024 Authors: Zhu Y; Banerjee A; Xie P; Ivanov AA; Uddin A; Jiao Q; Chi JJ; Zeng L; Lee JY; Xue Y -
New insights into KLFs and SOXs in cancer pathogenesis, stemness, and therapy.
Semin Cancer Biol Volume: 90 Page(s): 29 - 44
05/01/2023 Authors: Zeng L; Zhu Y; Moreno CS; Wan Y -
Proteolytic regulation of CD73 by TRIM21 orchestrates tumor immunogenicity.
Sci Adv Volume: 9 Page(s): eadd6626
01/06/2023 Authors: Fu Z; Chen S; Zhu Y; Zhang D; Xie P; Jiao Q; Chi J; Xu S; Xue Y; Lu X -
MnSOD Lysine 68 acetylation leads to cisplatin and doxorubicin resistance due to aberrant mitochondrial metabolism.
Int J Biol Sci Volume: 17 Page(s): 1203 - 1216
01/01/2021 Authors: Gao Y; Zhu Y; Tran EL; Tokars V; Dean AE; Quan S; Gius D -
SOD2 acetylation on lysine 68 promotes stem cell reprogramming in breast cancer.
Proc Natl Acad Sci U S A Volume: 116 Page(s): 23534 - 23541
11/19/2019 Authors: He C; Danes JM; Hart PC; Zhu Y; Huang Y; de Abreu AL; O'Brien J; Mathison AJ; Tang B; Frasor JM -
Lysine 68 acetylation directs MnSOD as a tetrameric detoxification complex versus a monomeric tumor promoter.
Nat Commun Volume: 10 Page(s): 2399
06/03/2019 Authors: Zhu Y; Zou X; Dean AE; Brien JO; Gao Y; Tran EL; Park S-H; Liu G; Kieffer MB; Jiang H -
Homeostatic Roles of STING in Cell Proliferation and Chromosomal Instability.
Cancer Res Volume: 79 Page(s): 1295 - 1296
04/01/2019 Authors: Gius D; Zhu Y -
Emerging evidence for targeting mitochondrial metabolic dysfunction in cancer therapy.
J Clin Invest Volume: 128 Page(s): 3682 - 3691
08/31/2018 Authors: Zhu Y; Dean AE; Horikoshi N; Heer C; Spitz DR; Gius D